Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11269335rdf:typepubmed:Citationlld:pubmed
pubmed-article:11269335lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:11269335lifeskim:mentionsumls-concept:C0596981lld:lifeskim
pubmed-article:11269335lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:11269335lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:11269335lifeskim:mentionsumls-concept:C0031164lld:lifeskim
pubmed-article:11269335lifeskim:mentionsumls-concept:C0013682lld:lifeskim
pubmed-article:11269335lifeskim:mentionsumls-concept:C1510800lld:lifeskim
pubmed-article:11269335pubmed:issue1lld:pubmed
pubmed-article:11269335pubmed:dateCreated2001-3-27lld:pubmed
pubmed-article:11269335pubmed:abstractTextGene delivery to the myocardium using blood-borne adenoviral vectors is hindered by the endothelium, which represents a barrier limiting the infection rate of underlying myocytes. However, endothelial permeability may be modulated by pharmacological agents.lld:pubmed
pubmed-article:11269335pubmed:languageenglld:pubmed
pubmed-article:11269335pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269335pubmed:citationSubsetIMlld:pubmed
pubmed-article:11269335pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11269335pubmed:statusMEDLINElld:pubmed
pubmed-article:11269335pubmed:issn1099-498Xlld:pubmed
pubmed-article:11269335pubmed:authorpubmed-author:MichelJ BJBlld:pubmed
pubmed-article:11269335pubmed:authorpubmed-author:MercadierJ...lld:pubmed
pubmed-article:11269335pubmed:authorpubmed-author:LogeartDDlld:pubmed
pubmed-article:11269335pubmed:authorpubmed-author:NevoNNlld:pubmed
pubmed-article:11269335pubmed:authorpubmed-author:GosgnachWWlld:pubmed
pubmed-article:11269335pubmed:authorpubmed-author:ChossatNNlld:pubmed
pubmed-article:11269335pubmed:issnTypePrintlld:pubmed
pubmed-article:11269335pubmed:volume3lld:pubmed
pubmed-article:11269335pubmed:ownerNLMlld:pubmed
pubmed-article:11269335pubmed:authorsCompleteYlld:pubmed
pubmed-article:11269335pubmed:pagination42-50lld:pubmed
pubmed-article:11269335pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:meshHeadingpubmed-meshheading:11269335...lld:pubmed
pubmed-article:11269335pubmed:articleTitleIncreasing endothelial cell permeability improves the efficiency of myocyte adenoviral vector infection.lld:pubmed
pubmed-article:11269335pubmed:affiliationINSERM U460, Faculté de Médecine Xavier Bichat, Paris, France. nevo@bichat.inserm.frlld:pubmed
pubmed-article:11269335pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11269335pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed